Lifestyle-related risk factors for dementia;Livsstil som risikofaktor for udvikling af demens

Ugeskrift for Laeger

Volumn 168, Issue 40, 2006, Pages 3401-3405

  Phung, Thien Kieu Thi ^a   Andersen, Kjeld ^b   Kessing, Lars Vedel ^b   Waldemar, Gunhild ^b  

^a H:S Hukommelsesklinikken   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; DEMENTIA; EDUCATION; HUMAN; INTELLIGENCE; LIFESTYLE; NUTRITION; PRENATAL PERIOD; REVIEW; RISK FACTOR; SENESCENCE; SOCIOECONOMICS;

ALZHEIMER DISEASE; BRAIN INJURIES; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEMENTIA; DEMENTIA, VASCULAR; ENVIRONMENTAL EXPOSURE; EXERCISE; FOOD HABITS; HUMANS; LIFE STYLE; MALNUTRITION; MENTAL DISORDERS; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 33749580234     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Sadowski M, Pankiewicz J, Scholtzova H et al. Links between the pathology of Alzheimer's disease and vascular dementia. Neurochem Res 2004;29:1257-66.
2. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4:487-99.
3. Forette F, Seux ML, Staessen JA et al. The prevention of dementia with anti-hypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002;162:2046-52.
4. Tzourio C, Anderson C, Chapman N et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-75.
5. Sastre AA, Grimley EJ. Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane Library, Issue 2, 2006. Chichester, UK: John Wiley & Sons.
6. Wolozin B, Kellman W, Ruosseau P et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000;57:1439-43.
7. Simons M, Schwarzler F, Lutjohann D et al. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 2002;52:346-50.
8. Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 2000;21:153-60.
9. Jick H, Zornberg GL, Jick SS et al. Statins and the risk of dementia. Lancet 2000;356:1627-31.
10. Dufouil C, Richard F, Fievet N et al. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 2005;64:1531-8.
11. Sparks DL, Sabbagh MN, Connor DJ et al. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol 2005;62:753-7.
12. Hulse GK, Lautenschlager NT, Tait RJ et al. Dementia associated with alcohol and other drug use. Int Psychogeriatr 2005;17(suppl 1):S109-S127.
13. Luchsinger JA, Tang MX, Siddiqui M et al. Alcohol intake and risk of dementia. J Am Geriatr Soc 2004;52:540-6.
14. Almeida OP, Hulse GK, Lawrence D et al. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 2002;97:15-28.
15. Holmang A. Perinatal origin of adult disease. Scand Cardiovasc J 2001;35:178-85.
16. Jorm AF. Is depression a risk factor for dementia or cognitive decline? Gerontology 2000;46:219-27.
17. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry 2004;75:1662-6.
18. Salerno-Kennedy R, Cashman KD. Relationship between dementia and nutrition-related factors and disorders: an overview. Int J Vitam Nutr Res 2005;75:83-95.
19. Malouf R, Grimley EJ, Sastre AA. Folic acid with or without vitamin B12 for cognition and dementia (review). The Cochrane Library, Issue 2, 2006. Chichester, UK: John Wiley & Sons.
20. Malouf R, Grimley EJ. Vitamin B6 for cognition (Review). The Cochrane Library, Issue 2, 2006. Chichester, UK: John Wiley & Sons.
21. Solfrizzi V, D'Introno A, Colacicco AM et al. Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp Gerontol 2005;40:257-70.
22. Kiraly MA, Kiraly SJ. The effect of exercise on hippocampal integrity: review of recent research. Int J Psychiatry Med 2005;35:75-89.
23. Scarmeas N, Stern Y. Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep 2004;4:374-80.
24. Bennett DA, Schneider JA, Wilson RS et al. Education modifies the association of amyloid but not tangles with cognitive function. Neurology 2005;65:953-5.
25. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 2004;3:343-53.
26. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 2002;14:125-30.
27. Weuve J, Kang JH, Manson JE et al. Physical activity, including walking, and cognitive function in older women. JAMA 2004;292:1454-61.
28. Podewils LJ, Guallar E, Kuller LH et al. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol 2005;161:639-51.
29. Larson EB, Wang L, Bowen JD et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006;144:73-81.
30. Rovio S, Kareholt I, Helkala EL et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 2005;4:705-11.
31. Colcombe SJ, Erickson KI, Raz N et al. Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol A Biol Sci Med Sci 2003;58:176-80.
32. Moceri VM, Kukull WA, Emanuel I et al. Early-life risk factors and the development of Alzheimer's disease. Neurology 2000;54:415-20.
33. Wilson RS, Scherr PA, Hoganson G et al. Early life socioeconomic status and late life risk of Alzheimer's disease. Neuroepidemiology 2005;25:8-14.
34. Turrell G, Lynch JW, Kaplan GA et al. Socioeconomic position across the life-course and cognitive function in late middle age. J Gerontol B Psychol Sci Soc Sci 2002;57:S43-S51.
35. Snowdon DA, Kemper SJ, Mortimer JA et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA 1996;275:528-32.
36. Abbott RD, White LR, Ross GW et al. Height as a marker of childhood development and late-life cognitive function: the Honolulu-Asia Aging Study. Pediatrics 1998;102:602-9.
37. Szczygielski J, Mautes A, Steudel WI et al. Traumatic brain injury: cause or risk of Alzheimer's disease? J Neural Transm 2005;112:1547-64.
38. Schmidt ML, Zhukareva V, Newell KL et al. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol (Berl) 2001;101:518-24.
39. Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 2005;113:1250-6.